Maj Mel Mann, Ret., MBA, M.Ed, Patient Advocate🎗️(@MelDMann) 's Twitter Profileg
Maj Mel Mann, Ret., MBA, M.Ed, Patient Advocate🎗️

@MelDMann

WORLD’S LONGEST LIVING GLEEVEC & Tyrosine Kinase Inhibitor TKI Survivor, 29 Yr #CML Survivor, Army Ret, CONNECT IF YOU’RE CONNECTED TO CANCER OR CLINICAL TRIALS

ID:47336979

linkhttp://g.co/kgs/SgCVaQ5 calendar_today15-06-2009 13:42:49

35,6K Tweets

502,2K Followers

259,2K Following

Follow People
CURE Today(@cure_today) 's Twitter Profile Photo

In our most recent , a CURE® reader asked how to manage 15 years into .

Here’s what retired nurse practitioner Jody Pelusi from Arizona Oncology (Arizona Oncology) had to say:
curetoday.com/view/how-to-fa…

account_circle
AACR(@AACR) 's Twitter Profile Photo

The AACR Clinical Oncology Research (CORE) Training Fellowship provides $100,000 for clinical research fellows to spend one year onsite with an industry partner like AstraZeneca to gain real-world drug development experience. Apply by May 31:
bit.ly/3UrVywl

The AACR Clinical Oncology Research (CORE) Training Fellowship provides $100,000 for clinical research fellows to spend one year onsite with an industry partner like AstraZeneca to gain real-world drug development experience. Apply by May 31: bit.ly/3UrVywl
account_circle
Urvi Shah(@UrviShahMD) 's Twitter Profile Photo

Only 4% of cancer survivors adhered to all 4 American Cancer Society guidelines, with the mean number met being 2
The guidelines
1. physical activity
2. body mass index
3. alcohol use
4. fruit & vegetable intake
Much work to be done to improve adherence!

jamanetwork.com/journals/jamao…

account_circle
The Leukemia & Lymphoma Society(@LLSusa) 's Twitter Profile Photo

Spread love and support on ! ❤️👇 Join us in spreading awareness and HOPE this year!

❤️ Our investment in game-changing breakthroughs like our Beat AML® Master Clinical Trial is improving outcomes. Because of this trial, some patients with a prognosis of…

Spread love and support on #AMLWorldAwarenessDay! ❤️👇 Join us in spreading awareness and HOPE this year! ❤️ Our investment in game-changing breakthroughs like our Beat AML® Master Clinical Trial is improving outcomes. Because of this trial, some patients with a prognosis of…
account_circle
Andrea Morehead(@Andrea_Morehead) 's Twitter Profile Photo

“I’m sorry.”

The incredible stories from brave people around the country about and are finally being told!

Our mission is clear.

To see the entire 1st episode:
youtu.be/YHD9N4lgnfo?si…

New YouTube show
MySilenceIsNotForSale

account_circle
Hagop Kantarjian,MD(@DrHKantarjian) 's Twitter Profile Photo

Dasatinib + Venetoclax is safe & effective in newly diagnosed in CP, but no better than single-agent dasatinib; longer follow-up needed to evaluate impact on TFR:
MD Anderson Cancer Center
ACS Journal Cancer
acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…

Dasatinib + Venetoclax is safe & effective in newly diagnosed #CML in CP, but no better than single-agent dasatinib; longer follow-up needed to evaluate impact on TFR: @MDAndersonNews #Leukemia @JournalCancer acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…
account_circle
Susan G. Komen(@SusanGKomen) 's Twitter Profile Photo

Everyone at Susan G. Komen is devastated to learn that our dear friend Sheila Johnson passed away this morning from metastatic breast cancer.

Everyone at Susan G. Komen is devastated to learn that our dear friend Sheila Johnson passed away this morning from metastatic breast cancer.
account_circle
Clinical Trials For All(@TrialsForAll) 's Twitter Profile Photo

takes all of us standing together and speaking up to address racial and ethnic minority health disparities. Raise awareness and offer solutions. ow.ly/KvXb50RgAGB

account_circle